quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 3, 2026

Global and China Intelligent Vehicle EEA and Technology Supply Chain Construction Strategy Research Report 2025 with EEA Upgrade and Evolution Trends of 17 Chinese OEMs and 7 International OEMs

View original at globenewswire.com
Global and China Intelligent Vehicle EEA and Technology Supply Chain Construction Strategy Research Report 2025 with EEA Upgrade and Evolution Trends of 17 Chinese OEMs and 7 International OEMs Dublin, Feb…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Sentry Mode reduces power consumption by 40%, leading to an additional 16km of range for the vehicle

    80% confidence
  • The four-in-one domain controller achieves 57% reduction in size and 75% fewer parts compared to traditional distributed architecture

    80% confidence
  • 640,000 passenger cars with quasi-central + zonal architectures were sold in 2025H1 with a share of 6.1%

    80% confidence
  • 299,000 passenger cars with central + zonal architectures were sold in 2025H1 with a share of 2.8%

    80% confidence
  • The penetration rate of quasi-central + zonal architectures will reach 25.2% by 2030

    80% confidence
  • The four-in-one domain controller enables 15-minute OTA updates

    80% confidence
  • The penetration rate of central + zonal architectures will reach 17.5% by 2030

    80% confidence
  • 802,000 passenger cars with domain fusion architectures were sold in 2025H1, accounting for 7.6% market share

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Global and China Intelligent Vehicle EEA and Technology Supply Chain Construction Strategy Research Report 2025 with EEA Upgrade and Evolution Trends of 17 Chinese OEMs and 7 International OEMs — Source | Via News | pt.VIA.NEWS